3efk
From Proteopedia
Contents |
Structure of c-Met with pyrimidone inhibitor 50
Template:ABSTRACT PUBMED 18763753
Disease
Known disease associated with this structure: Hepatocellular carcinoma, childhood type OMIM:[164860], Renal cell carcinoma, papillary, familial and sporadic OMIM:[164860], Autism, suseptibility to, 9 OMIM:[164860]
About this Structure
3EFK is a 2 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- D'Angelo ND, Bellon SF, Booker SK, Cheng Y, Coxon A, Dominguez C, Fellows I, Hoffman D, Hungate R, Kaplan-Lefko P, Lee MR, Li C, Liu L, Rainbeau E, Reider PJ, Rex K, Siegmund A, Sun Y, Tasker AS, Xi N, Xu S, Yang Y, Zhang Y, Burgess TL, Dussault I, Kim TS. Design, synthesis, and biological evaluation of potent c-Met inhibitors. J Med Chem. 2008 Sep 25;51(18):5766-79. PMID:18763753 doi:10.1021/jm8006189
Page seeded by OCA on Tue Feb 17 08:42:28 2009
Categories: Homo sapiens | Receptor protein-tyrosine kinase | Angelo, N D. | Bellon, S F. | Dussault, I. | Whittington, D. | Alternative splicing | Atp-binding | C-met | Chromosomal rearrangement | Disease mutation | Glycoprotein | Kinase | Kinase inhibitor pyrimidone | Membrane | Nucleotide-binding | Phosphoprotein | Polymorphism | Proto-oncogene | Receptor | Transferase | Transmembrane | Tyrosine-protein kinase